Report Scope:
The scope of this report is broad and covers various types of products available in the cell line and membrane market and potential application sectors across various industries. The cell line and membrane market is segmented by cell line product type and membrane type. Revenue forecasts from 2018 to 2023 are given for each product, application and end user with estimated values derived from the total revenue of manufacturers.

The report also includes a discussion of the major players across each region in the cell line and membrane market. Further, it explains the major drivers and regional dynamics of the global cell line and membrane market and current trends within the industry.



The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors in the cell line and membrane market.

Report Includes:

  • 79 data tables and 60 additional tables
  • Identification of applications of cell lines in drug development, diagnostics, and molecular biology
  • Description of advancements in cell lines for cancer-based therapies
  • Details of CAR-T Cell and immune check point inhibitor therapy
  • Comparative study of autologous vs allogenic cells manufacturing process
  • Explanation of increasing adoption of cell line technologies in cell-based assay and surging demand of antibody production as a driving force to the cell line market
  • Detailed profiles of the major vendors in the global cell line and membrane market, including ATCC, GE Healthcare, Lonza Group Ltd., Sartorius, Thermo Fisher Scientific and Wuxi AppTec